glutathione and uric acid Antioxidant Metabolism Pathways in Vitamins, Polyphenols, Selenium: Parallels and Divergences Glutathione: Lights and Shadows in
Description
Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent
Our findings support additional validation of ArfGAP1 as a putative therapeutic target for modulating LRRK2 -linked PD
Ageing Res
Two sets of sealed code break envelopes were supplied
Neuromedin U physiology, pharmacology and therapeutic potential
Alzheimer's Dementia Transl
